Kleiner's hit (and miss) parade

Kleiner Perkins has long defined the gold standard for venture capital. The Kleiner hit parade stretches back 36 years and includes early bets on industry icons like Genentech, Amazon and Google. Here are a few of the bets that made it famous, as well as some it might like to forget.

1 of 8
BACK NEXT
Genentech
Genentech
The biotech was Kleiner's first big hit, and helped start the biotechnology industry. It went public in 1980 at $35 per share -- after an hour on the market, shares were trading at $80.
NEXT: Go
Last updated July 19 2008: 1:57 PM ET
More Galleries
Google turns 10: A look back As the search giant celebrates its birthday, we highlight some of its biggest moments. (more)
J.P. Morgan Chase CEO Jamie Dimon is in a position to go bargain hunting while his competitors mainly suffer on the sidelines. Here are four possible acquisitions. (more)
5 record-breaking biotech deals The one bright spot in M&A in 2008 are drugmakers, where giant pharmaceutical companies are paying record amounts for biotechs to replenish their pipelines. (more)
* : Time reflects local markets trading time.† - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges.• Disclaimer